Definitive Contract N6264517C4023

Award Date 8/31/17
Potential Completion Date 5/31/18
Potential Value $3.8M
Ultimate Awardee
Leidos Holdings, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Poquonock Bridge, CT 06340, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,635,548.83, was issued by the Bureau of Medicine and Surgery, a defense agency, to the prime contractor Leidos, Inc. The contract is for research and development support services, with a period of performance ending on May 31, 2025. The contract does not have a set-aside designation, indicating Leidos' competitive capabilities across federal procurement. Leidos, a global leader in information technology, engineering, and scientific solutions, will...
This is a federal contract awarded by the Bureau of Medicine and Surgery, a defense agency within the Department of the Navy, to Leidos, Inc. The contract is for research and development support services, with a ceiling value of $9,675,749.88 and a completion date of May 31, 2025. No set-aside designation was used for this competitively awarded contract. Leidos, a global technology and engineering solutions provider, will deliver a range of technical, scientific, and administrative services to...
This federal contract award, valued at $10,708,546.59, was issued by the Bureau of Medicine and Surgery (BUMED) to Leidos, Inc. for research support services for the Naval Health Research Center. The contract has an ultimate completion date of September 17, 2025 and is a cost plus fixed fee delivery order. Leidos will provide a range of research and support services, likely including activities related to medical research programs, IT modernization, logistics, and specialized equipment...
This is a $4,907,547.53 cost-plus-fixed-fee delivery order contract awarded to Leidos, Inc. by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to provide research support services. The contract has an ultimate completion date of September 17, 2025. Leidos, Inc. is a global technology and engineering solutions provider that has secured numerous federal prime contracts and subcontracts across different agencies and domains, including research, IT,...
This is a delivery order under the Navy Medicine R&D Support Omnibus III contract, awarded by the Bureau of Medicine and Surgery (a Defense agency) to Leidos, Inc. for $10,434,530.44. The contract is for medical research program support, including services related to conditions such as traumatic brain injury, cancer, autism, and rare diseases. Leidos has subcontracted work to several companies, including Icon Government And Public Health Solutions, Inc., Camris International, LLC, and...
This federal contract award to Leidos, Inc. is for sleep therapy research on behalf of the U.S. Navy Bureau of Medicine and Surgery, a component of the Department of Defense. The $17,361,378.60 cost-plus-fixed-fee contract has a period of performance through February 28, 2030 and was not set aside for any specific business category. Leidos, the prime contractor, is a major technology and engineering solutions provider to the federal government, with a strong track record of delivering medical...
This federal contract was awarded by the Defense Health Agency to Leidos, Inc. to provide combat readiness medical research program support services for fiscal year 2024. The contract has a potential ceiling value of $228,327.39 and is a cost-plus-fixed-fee delivery order. The contract is not set aside for any specific business categories. Leidos, a global technology and engineering solutions provider, will deliver a range of technical, scientific, and administrative services to support critical...
This is a delivery order contract awarded by the Defense Health Agency to Leidos, Inc. with a potential value of $143,956.66. The contract is for general program support services, with a period of performance from May 2015 to May 2016. It is a time and materials contract, which indicates the work is being performed on an as-needed basis. The contract does not have a set-aside designation. Leidos, Inc. is a global technology and engineering solutions provider that has supported various federal...
This federal contract award, W81XWH17D0025|W81XWH22F0223, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense for the Fiscal Year 2022 Defense Medical Research and Development Program (FY22 DMDRP). The $99,864.13 Cost Plus Fixed Fee delivery order was awarded to Leidos, Inc., a global technology and engineering solutions provider, through its Leidos Services Operating Segment division. The contract does not have a set-aside designation. The award supports medical...
This is a $87,336,531.28 cost-plus-fixed-fee delivery order contract awarded by the Bureau of Medicine and Surgery, a Defense agency, to Leidos, Inc. for deployment health research. The contract has a period of performance through February 2030. Leidos has a significant portfolio of federal contracts and subcontracts across multiple agencies, including the Department of Defense, NASA, and civilian organizations, demonstrating broad technical and administrative capabilities. This specific award...

This federal contract award was made by the Bureau of Medicine and Surgery, a Defense agency, to the prime contractor Leidos, Inc. for $3,774,462.04 in R&D support services. The contract is a Cost Plus Fixed Fee Definitive Contract with a period of performance through May 2018. It is not designated as a set-aside contract.

As a global leader in information technology and engineering solutions, Leidos has supported numerous federal agencies through both prime and subcontract awards. For this contract, Leidos utilized subcontractors MAK Technologies, Inc. and Creare LLC to provide procured goods and services in support of the statement of work. MAK Technologies is a foreign-owned firm specializing in military simulation technologies, while Creare LLC is an engineering research and development company with expertise across defense, aerospace, and energy domains. This award appears to be part of the Bureau of Medicine and Surgery's broader medical research programs, which may include focus areas such as traumatic brain injury, psychological health, cancer, and rare diseases.

Generated 9/11/24, 10:19 AM